ARRAY BIOPHARMA INC's ticker is ARRY and the CUSIP is 04269X105. A total of 113 filers reported holding ARRAY BIOPHARMA INC in Q3 2014. The put-call ratio across all filers is 0.54 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2014 | $257,000 | -32.9% | 72,009 | -14.3% | 0.00% | – |
| Q2 2014 | $383,000 | -18.9% | 83,992 | -16.4% | 0.00% | – |
| Q1 2014 | $472,000 | +67.4% | 100,417 | +78.6% | 0.00% | – |
| Q4 2013 | $282,000 | -9.0% | 56,240 | +12.7% | 0.00% | – |
| Q3 2013 | $310,000 | +105.3% | 49,905 | +49.1% | 0.00% | – |
| Q2 2013 | $151,000 | – | 33,464 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Redmile Group, LLC | 17,224,428 | $281,103,000 | 10.86% |
| BVF INC/IL | 5,062,768 | $82,624,000 | 8.38% |
| First Light Asset Management, LLC | 1,675,148 | $27,338,000 | 6.00% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 851,500 | $13,888,000 | 5.42% |
| EcoR1 Capital, LLC | 3,049,312 | $49,765,000 | 4.99% |
| X-Square Capital, LLC | 167,338 | $2,731,000 | 2.88% |
| Eversept Partners, LP | 357,727 | $5,838,105 | 2.71% |
| SECTORAL ASSET MANAGEMENT INC | 1,031,650 | $16,837,000 | 1.85% |
| Copernicus Capital Management, LLC | 131,418 | $2,145,000 | 1.71% |
| Asymmetry Capital Management, L.P. | 81,649 | $1,333,000 | 1.67% |